Comments on: Sansrosa starts Phase II strength tests, still a long way to go

By: David Pascoe

David Pascoe — Fri, 19 Mar 2010 01:13:25 +0000

Sounds like a reasonable guess George. You might even be able to grow the market for this product by selling 3 strengths – splitting the users into 3 groups.

All speculation of course, but it might also be just the Galderma wasn’t happy with the trials so far and themselves do things differently compared to how Collagenex and Sansrosa executed.

davidp.

By: George

George — Thu, 18 Mar 2010 19:00:59 +0000

Cont:

Also if Galderma thought there was a high chance of Sansrosa not succeeding in the tests why would they be looking at a higher dosage of the product?

Maybe these are simply the steps they need to take to offer a higher dosage??

George

By: George

George — Thu, 18 Mar 2010 18:24:38 +0000

Hey all,

I read in a different article that Galderma wanted to increase the dosage of sansrosa.

Is it not possible that they have already started the phase 3 testing but because they feel that they may be able to offer a stronger dosage they have had to alter their stage 2 testing slightly to enable this to happen?

Regards

George

By: David Pascoe

David Pascoe — Wed, 17 Mar 2010 00:51:45 +0000

It seems clear to me given that the product is back at Phase II testing, it is highly unlikely that the Phase III testing can be completed and approval granted in 2010.

Additionally, you would have to be a real optimist to believe 2011 is likely.

davidp.

By: Tom

Tom — Tue, 16 Mar 2010 13:58:27 +0000

Hi Guys:

Everything I had read indicated a possible release date this year. So is 2010 still a realistic target date or has the above info delayed it’s launch?

Thanks!

By: Beavis

Beavis — Thu, 11 Feb 2010 23:33:06 +0000

I suffer from KPRF also (6 ipl treatments done 4 years from which I got good results ,but redness/flushing is back nearly as bad as ever ) . The over production of keratin seems to be what causes the blood vessel damage/growth in KPRF .Hopefully when sansrosa hits the market it will be helpfull to us KPRF sufferers also. Does anyone know will it be safe to use in the long term? Due to the nature of KP & the excess keratin production , the underlying problem will not be curtailed, only (hopefully) the redness/inflamation and long term usage will probobly be needed.

By: El dictator

El dictator — Thu, 14 Jan 2010 19:58:30 +0000

thanks davo,
The mild to medium underlying redness and redness flare-ups / flushing is really what Im going for, so it sounds good and gives my mind a little relief that there’s something…
Now whether it’ll work for myself or whether it’s coming to the u.k and will be prescribed by an nhs doctor is another matter

By: David Pascoe

David Pascoe — Thu, 14 Jan 2010 02:46:40 +0000

Nothing new to report, we are just sitting and waiting.

Sansrosa will officially be targeted for the redness of rosacea, any other symptoms relieved will be a bonus.

THE Dictactor,
davidp.

By: El dictator

El dictator — Thu, 14 Jan 2010 01:39:26 +0000

davo, are we any closer to a release yet?
Am I right in saying this is just for the constant and underlying redness/erythema?

By: David Pascoe

David Pascoe — Wed, 25 Nov 2009 07:28:28 +0000

Hi DukeCity,

You are right in that Galderma appears set to reap the rewards from their investment in Rosacea R&D.

Lets hope that they use those future profits to fund more novel research.

davidp.